Extranodal marginal zone lymphoma: a case report and review of the literature
Yepes, J.F.; Alawi, F.; Stanton, D.C.; Stoopler, E.T.
General Dentistry 53(5): 335-338
2005
ISSN/ISBN: 0363-6771 PMID: 16252536 Document Number: 594100
The World Health Organization (WHO) defines extranodal marginal zone lymphoma (MZL) as an indolent B-cell lymphoma. This disease involves a heterogeneous group of B-cell tumors that occurs primarily within the lymph nodes, spleen, or extranodal tissues. Initial MZL treatment consists of chemotherapy and/or radiotherapy and is associated with a high survival rate when detected early. This article highlights an unusual case of extranodal MZL in the parotid area.